New Study Confirms Bioavailability of FloraGlo Lutein
A new study underlines the superior bioavailability of FloraGlo lutein, combined with Actilease beadlet technology, to the eye’s macula. The study was performed by Kemin Health LC (Des Moines, IA), developer of FloraGlo, and DSM Nutritional Products (Parsippany, NJ), developer of Actilease.
A new study underlines the superior bioavailability of FloraGlo lutein, combined with Actilease beadlet technology, to the eye’s macula. The study was performed by Kemin Health LC (Des Moines, IA), developer of FloraGlo, and DSM Nutritional Products (Parsippany, NJ), developer of Actilease.
The randomized, double-blind, two-phase, crossover study provided 48 healthy subjects with either 20 mg of unesterified lutein in an alginate matrix or FloraGlo lutein microencapsulated using Actilease. Using Actilease, FloraGlo is broken into microparticles that are housed in a water-soluble shell.
Macular pigment optical density (MPOD), which may be a biomarker for age-related macular degeneration, was measured. The study found that MPOD after the FloraGlo treatment was 0.45 µmol/L (a 169.7% increase from baseline), versus a lower 0.23 µmol/L MPOD level (a 34.5% increase from baseline) resulting from the alternative treatment.
The companies say this study supports FloraGlo’s efficacy and are using it as evidence to point out that “not all lutein sources are equally bioavailable.”
Rousselot to showcase new collagen peptide research and targeted solutions at Vitafoods Europe 2024
April 25th 2024The company will be highlighting new research that demonstrates the ability of its Peptan collagen peptide brand to support sleep quality, reduce gastrointestinal discomfort, and enhance skin health, including density, hydration, and elasticity.
The Nutritional Outlook Podcast Episode 29: 2024 Ingredients to Watch
January 31st 2024Nutritional Outlook interviews Scott Dicker, market insights director from market researcher SPINS, about ingredients and product categories nutraceutical and nutrition product manufacturers should watch in 2024.
